Rheuma Pain Ii Drops
Generic Name: rheuma pain ii drops
Brand Names:
Rheuma Pain Ii Drops 2058
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Overview
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
INDICATIONS For the temporary relief of mild pain, inflammation, or stiffness in joints, muscles, or surrounding tissue, particularly when improved by applying cold.*
Dosage
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day for up to 6 weeks. For immediate onset of symptoms, take 10 to 15 drops every 15 minutes up to 3 hours. For less severe symptoms, take 10-15 drops hourly up to 8 hours. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Frequently Asked Questions
What is Rheuma Pain Ii Drops used for?▼
INDICATIONS For the temporary relief of mild pain, inflammation, or stiffness in joints, muscles, or surrounding tissue, particularly when improved by applying cold.*
Can I take Rheuma Pain Ii Drops during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Rheuma Pain Ii Drops?▼
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Related Medications
Benzonatate
benzonatate
Non-narcotic Antitussive [EPC]
Benzonatate is a non-narcotic oral antitussive (cough suppressant) agent available in 100 mg, 150 mg, and 200 mg capsules.
Tarlatamab-dlle
tarlatamab-dlle
11 DESCRIPTION Tarlatamab-dlle is a bispecific DLL3-directed CD3 T-cell engager that binds to DLL3 expressed on the surface of cells, including tumor cells, and CD3 expressed on the surface of T cells. Tarlatamab-dlle is produced using recombinant DNA technology in Chinese hamster ovary cells. It consists of 982 amino acids and has a molecular weight of approximately 105 kilodaltons.
Selenicereus Grandiflorus Stem, Crataegus Laevigata Fruit, And Spigelia Anthelmia
selenicereus grandiflorus stem, crataegus laevigata fruit, and spigelia anthelmia
Pericarditis, angina pectoris, dyspnea, endocarditis.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.